Dr Reddys lab is 1265 today risen from the low of 415 during the year----an appreciation of over 300 %. What led to this phenomenal rise of this stock? Any possible target up to March 2011?
Application (ANDA) approvals and four tentative ANDA approvals in 2009. Alliance with Glaxo SmithKline (GSK) to enable them develop & market over 100 products across an extensive number of emerging markets. One can hold with a strict stop loss for an upside of 1350 - 1400 in the short term while for the next year the target is 1600 plus!!
Now compare this with a few random examples of stock, of which I am intimately familiar with, have been tracking them for donkey's years and know their movement by heart for more than the past 3 years.
Here it goes:
Tata Motors - 135 to 900 Plus - 6.5 times.
Suzlon - 33 to 147 - 4.5 times.
Siemens - 165 - 748 - 4.5 times.
IDFC - 41 to 178 - 4.4 times. ...more